Compare Moderna, Inc. (MRNA) vs Wayfair Inc (W) Price & Performance

Moderna, Inc.Trade

Wayfair IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Wayfair Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Wayfair Inc trades at $84.8 (market cap $11.58B). The key difference: Moderna, Inc. is far larger — about 2× Wayfair Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Wayfair Inc nearer its low. Which is the better fit depends on your goals.

	MRNA	W
Market Cap	$23.60B	$11.58B
Sector	Health	Consumer Cyclical
52-Week High	$81.80	$119.05
52-Week Low	$22.36	$56.42
Enterprise Value	$19.70B	$14.16B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

SpaceX launch aborted, Netflix misses revenue expectations, Wayfair plans big summer sale, STAAR Surgical shares drop.Seeking Alpha · 4 days agoBearish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Wayfair Inc

Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.